Thiogenesis Therapeutics, Corp. (TSXV:TTI)
Canada
· Delayed Price · Currency is CAD 0.7500
+0.0400 (5.63%)
May 28, 2025, 9:30 AM EDT
Thiogenesis Therapeutics Market Cap
Thiogenesis Therapeutics has a market cap or net worth of CAD 32.21 million as of May 30, 2025. Its market cap has decreased by -14.97% in one year.
Market Cap
32.21M
Enterprise Value
29.20M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.75
Market Cap Chart
Since April 13, 2022, Thiogenesis Therapeutics's market cap has increased from 13.96M to 32.21M, an increase of 130.83%. That is a compound annual growth rate of 30.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 32.21M | 17.97% |
| Dec 31, 2024 | 27.31M | -18.31% |
| Dec 29, 2023 | 33.43M | 48.30% |
| Dec 30, 2022 | 22.54M | 61.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| dentalcorp Holdings | 1.76B |
| Sienna Senior Living | 1.72B |
| Green Thumb Industries | 1.68B |
| Extendicare | 1.21B |
| Cronos Group | 1.05B |
| Trulieve Cannabis | 1.05B |
| WELL Health Technologies | 1.04B |
| Curaleaf Holdings | 863.36M |